The influence caused by the GnRH and intra-uterine gestational sac “Mirena” hormone therapy on the clinical progression and homeostasis indexes as well as the uterine functional state among women with adenomyosis, endometrium hyperplasia accompanied by the endo- and myometrium pathology in dynamics was studied. New components of the non-cancerous uterus pathology development caused by the endometrium receptive function disorder were established. Complex phase hormone therapy for the reproductive age women with the non-cancerous uterus pathology was developed; its effect on the endometrium receptive function was evaluated .
